Partners

The Global Burden of Disease Brain Summit is a collaboration between AUT, The Lancet Neurology and the Global Burden of Disease (GBD) study which is coordinated by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

We would also like to thank our sponsors – Bayer, Brain Research New Zealand, Epilepsy Foundation, National Science Challenges: Ageing Well, Neurological Foundation of New Zealand , and New Zealand Multiple Sclerosis Research Trust.